Lilly Expands U.S. Injectable Manufacturing With $3.5B Site
INDIANAPOLIS / LEHIGH VALLEY, Pa., Jan. 30, 2026 — Eli Lilly announced plans to invest more than $3.5 billion...
Pharmaceutical Manufacturing
Advertisement
Peptinovo Advances Targeted Chemotherapy Manufacturing
ANN ARBOR, Mich., Dec. 17, 2025 — Peptinovo Biopharma, in collaboration with Chemelectiva S.r.l., announced a breakthrough manufacturing and...
Novartis Launches Flagship U.S. Hub to Secure Drug Manufacturing
EAST HANOVER, N.J. — December 12, 2025 — Novartis, a global innovative medicines company, has officially broken ground on...
Leadership Shift at Vetter Signals New Phase in Global GMP Manufacturing Strategy
Ravensburg, Germany — December 3, 2025 — Vetter Pharma-Fertigung GmbH & Co. KG, a global contract development and manufacturing...
Piramal Pharma Reports Q2 & H1 FY26 Results, Strengthens Global CDMO and Generics Capabilities
Dateline – Mumbai, India, November 5, 2025:Piramal Pharma Limited (NSE: PPLPHARMA, BSE: 543635), a leading global pharmaceutical, health and...
Advertisements
Rapid Micro Biosystems Highlights Growth Direct Automation at Stifel 2025
Lexington, Massachusetts – October 30, 2025 — Rapid Micro Biosystems, Inc. (Nasdaq: RPID), a leader in automated microbial quality...
Sai Life Sciences Launches Veterinary API Facility in Bidar
Hyderabad, India — September 18, 2025 — Sai Life Sciences has inaugurated Unit VI, a dedicated facility for the...
Precision Tablet Manufacturing Improved at Piramal’s Morpeth Facility
September 16, 2025 — Morpeth, United Kingdom Piramal Pharma Solutions, a leading global Contract Development and Manufacturing Organization (CDMO),...
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has approved its risperidone...
Advertisement
